Development and characterization of different low methoxy pectin microcapsules by an emulsion-interface reaction technique.
In the controlled release area, biodegradable microcapsules are one of the most useful devices to deliver materials in an effective, prolonged and safe manner. A new charged film microcapsular carrier system, using three different pectins, is described. The study utilized pectin microcapsules prepared by two encapsulation mechanisms of interfacial reaction explored through interaction of charged droplet-oil-anionic surfactant-calcium or oil-cationic surfactant with negatively charged pectin. A method for drug encapsulation was developed based on the type of pectin, surfactants and emulsification technique. Both types of surfactant, anionic sodium dodecyl sulphate (SDS) and cationic benzalkonium chloride (BzACl) promoted polymer film formation on the oil droplet surfaces, probably through cross-linking and electrostatic interaction, respectively. Microcapsules consisting of pectin as shell and hydrophobic oil as core were characterized. The resulting microcapsules were relatively small particles (d< 3 microm), had high total particle number, specific surface area and drug encapsulation efficiency. They also demonstrated good stability with minimum particle aggregation. Correlation between physicochemical and drug release kinetic parameters were investigated with regard to the effect of pectin macromolecular structure and nature of surfactant used as a counterion in the manufacturing of microcapsules. The release rate of the encapsulated material (prednisolone) in three microcapsules can be controlled by manipulating the conformational flexibility of pectins in the presence of different counterions. As a result, biodegradable pectin microcapsules offer a novel approach for developing sustained release drug delivery systems that have potential for colonic drug delivery.
Muhiddinov
Z
Z
Chemistry Institute of Tajik National Academy of Sciences, 734063 Dushanbe, Tajikistan.
Khalikov
D
D
Speaker
T
T
Fassihi
R
R
D000893:Anti-Inflammatory Agents / Q000493:pharmacokinetics*; D001548:Benzalkonium Compounds; D003692:Delayed-Action Preparations; D004339:Drug Compounding / Q000379:methods; D004655:Emulsions; D008863:Microspheres; D010368:Pectins; D011239:Prednisolone / Q000493:pharmacokinetics*; D012967:Sodium Dodecyl Sulfate; D013501:Surface-Active Agents
D000893:Anti-Inflammatory Agents; D001548:Benzalkonium Compounds; D003692:Delayed-Action Preparations; D004655:Emulsions; D013501:Surface-Active Agents; D012967:Sodium Dodecyl Sulfate; D010368:Pectins; D011239:Prednisolone